Paediatric or syndromic cardiomyopathy
Gene: DNM1LEnsemblGeneIds (GRCh38): ENSG00000087470
EnsemblGeneIds (GRCh37): ENSG00000087470
OMIM: 603850, Gene2Phenotype
DNM1L is in 12 panels
1 review
Agnese Zarina (Children's Clinical University Hospital; Rīga, Latvia)
I recommend the inclusion of DNM1L in the Cardiomyopathy Panel with a Green rating, particularly for childhood-onset and syndromic cardiomyopathies.
DNM1L encodes dynamin-related protein 1 (DRP1), a key regulator of mitochondrial and peroxisomal fission. Pathogenic DNM1L variants are associated with mitochondrial fission disorders, predominantly characterised by neurological manifestations. However, accumulating clinical and functional evidence demonstrates that cardiomyopathy is an important, potentially life-threatening manifestation of DNM1L-related disease.
Cardiomyopathy has been reported in multiple unrelated patients carrying different de novo heterozygous pathogenic DNM1L variants, including p.(Glu410Lys), p.(Ser39Asn), and p.(Gly401Ser). Reported cardiac manifestations include hypertrophic cardiomyopathy, severe mitochondrial cardiomyopathy, progressive heart failure, cardiogenic shock, and fatal outcomes.
Importantly, the association is supported by functional studies demonstrating impaired mitochondrial dynamics, altered DRP1 function, and dominant-negative effects. Experimental animal models have also demonstrated that DNM1L dysfunction can directly cause cardiomyopathy.
These findings provide clinical, molecular, and functional evidence supporting DNM1L as a cardiomyopathy-associated gene. The available evidence is particularly relevant to early-onset cardiomyopathy associated with neurological or other mitochondrial manifestations.
Based on reports from at least three unrelated patients with cardiomyopathy, together with functional and experimental evidence, I recommend a Green (diagnostic-grade) rating for DNM1L in the Cardiomyopathy Panel, consistent with the Genomics England PanelApp criteria.
Mode of inheritance: MONOALLELIC, autosomal dominant (primarily de novo), for the reported cardiomyopathy-associated phenotype. Biallelic is not proven for cardiomyopathies.
Sources: LiteratureCreated: 9 Nov 2026, 9:04 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
DNM1L-related mitochondrial fission disorder with cardiomyopathy; hypertrophic cardiomyopathy; encephalocardiomyopathy.
Publications
Mode of pathogenicity
Other
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
- Sources
-
- Phenotypes
-
- DNM1L-related mitochondrial fission disorder with cardiomyopathy
- hypertrophic cardiomyopathy
- encephalocardiomyopathy.
- OMIM
- 603850
- Clinvar variants
- Variants in DNM1L
- Penetrance
- Complete
- Publications
- Mode of Pathogenicity
- Other
- Panels with this gene
-
- Intellectual disability
- Peroxisomal disorders
- Paediatric or syndromic cardiomyopathy
- Early onset or syndromic epilepsy
- Dystonia, chorea or related movement disorder, childhood onset
- Likely inborn error of metabolism
- Undiagnosed metabolic disorders
- Optic neuropathy
- DDG2P
- Possible mitochondrial disorder, nuclear genes
- Mitochondrial disorders
- Fetal anomalies
History Filter Activity
Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance, Set mode of pathogenicity
Agnese Zarina (Children's Clinical University Hospital; Rīga, Latvia)gene: DNM1L was added gene: DNM1L was added to Paediatric or syndromic cardiomyopathy. Sources: Literature Mode of inheritance for gene: DNM1L was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: DNM1L were set to PMID: 31587467, 39063023, 39859560, 35914810, 20585624. Phenotypes for gene: DNM1L were set to DNM1L-related mitochondrial fission disorder with cardiomyopathy; hypertrophic cardiomyopathy; encephalocardiomyopathy. Penetrance for gene: DNM1L were set to Complete Mode of pathogenicity for gene: DNM1L was set to Other Review for gene: DNM1L was set to GREEN